UVEITIS
Clinical trials for UVEITIS explained in plain language.
Never miss a new study
Get alerted when new UVEITIS trials appear
Sign up with your email to follow new studies for UVEITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with Arthritis-Related eye disease
Disease control CompletedThis trial tested whether the drug adalimumab could reduce painful eye inflammation (uveitis) in children with juvenile arthritis. The study involved 34 children whose eye inflammation did not improve with standard steroid drops and methotrexate. For the first two months, half re…
Matched conditions: UVEITIS
Phase: PHASE2, PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New injection treatment tested for blinding eye inflammation
Disease control CompletedThis study tested whether injections of ACTH gel could help control non-infectious uveitis, a serious inflammatory eye disease that can lead to blindness. Twenty-eight patients with active or recently active uveitis received injections either two or three times per week for six m…
Matched conditions: UVEITIS
Phase: PHASE2 • Sponsor: Quan Dong Nguyen • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Hospital tests cheaper copy of popular arthritis drug
Disease control CompletedThis study looked at whether patients could safely switch from the brand-name drug Remicade to a very similar, lower-cost version called Inflectra. It involved 262 patients at a Paris hospital who were already using Remicade for conditions like rheumatoid arthritis or Crohn's dis…
Matched conditions: UVEITIS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
Head-to-Head showdown: three powerful drugs battle blinding eye disease
Disease control CompletedThis study directly compared three biologic medications (adalimumab, anakinra, and tocilizumab) for treating severe uveitis that doesn't respond to standard treatments. Researchers enrolled 112 adults with this serious eye inflammation that can lead to blindness. The trial aimed …
Matched conditions: UVEITIS
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Eye inflammation diagnosis could cost half as much with new method
Diagnosis CompletedThis study tested a new, step-by-step method for finding the cause of uveitis, a type of eye inflammation. Researchers compared this new, standardized approach to the usual method where doctors freely choose tests. The goal was to see if the new method was just as good at finding…
Matched conditions: UVEITIS
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Mar 30, 2026 14:27 UTC
-
Scientists build a 'Library' of eye disease clues to crack the code of blinding inflammation
Knowledge-focused CompletedThis study aimed to build a long-term collection of health information and biological samples from people with uveitis, a serious inflammatory eye disease. Over 10 years, researchers followed 343 participants to gather data and samples like blood and tears. The goal was to discov…
Matched conditions: UVEITIS
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
Scientists hunt for gut clues to mysterious eye disease
Knowledge-focused CompletedThis study aimed to understand if the natural bacteria in a person's gut are related to uveitis, a group of inflammatory eye diseases. Researchers compared stool and blood samples from 131 adults with uveitis to samples from healthy adults without the condition. The goal was to g…
Matched conditions: UVEITIS
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC
-
Doctors use High-Tech scans to watch eye treatment in action
Knowledge-focused CompletedThis study aimed to understand how a steroid implant for uveitis (eye inflammation) affects the eye over time. Researchers followed 30 patients with active uveitis for 12 months after they received the implant. They used special eye scans to measure inflammation and see how it re…
Matched conditions: UVEITIS
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC